Get alerts when MRK.DE reports next quarter
Set up alerts — freeMerck reported 5.1% organic sales growth in Q3 and raised full-year guidance; the shares fell 1.3%, a roughly flat reaction. Growth in Life Science and Electronics was tempered by accelerating Mavenclad erosion in U.S. Specialty Care and expected further headwinds in consumer electronics.
See MRK.DE alongside your other holdings
Add to your portfolio — freeTrack MERCK Kommanditgesellschaft auf Aktien in your portfolio with real-time analytics, dividend tracking, and more.
View MRK.DE Analysis